Fresenius Kabi`s Tyenne (tocilizumab) Receives Approval in Europe
Fresenius Kabi`s Biologic Chorionic Gonadotropin Receives Approval in the U.S.
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today that its Ivenix® Infusion System has been selected by the Metrodora Institute to meet the Institute’s infusion medicine needs. The Metrodora Institute is an integrated, multidisciplinary medical and research center dedicated to treating neuroimmune axis disorders.
Fresenius Kabi Launches Single-Needle Option for the Amicus® Extracorporeal Photopheresis Protocol
Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix Infusion System
Enforcement Report - Week of January 25, 2023
Fresenius Kabi Deutschland`s Biologic Stimufend (pegfilgrastim) Receives Approval in Europe
Health Canada Issues Recall of Fresenius Kabi Canada Sodium Acetate Injection, USP: Particulate matter
Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter